ArticleInternational journal of clinical oncology2021
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.
Makoto Tahara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
74 papers cite itlatest 60 shown
this papercites it